SkylineDxs, Merlin SkylineDx's Merlin Assay stratifies Stage I / II cutaneous melanoma beyond SLNB for recurrence 07.08.2025 - 18:04:18 SkylineDx Netherlands United States of America United Kingdom View original content:https://www.prnewswire.co.uk/news-releases/skylinedxs-merlin-assay-stratifies-stage-iii-cutaneous-melanoma-beyond-slnb-for-recurrence-302158266.html
